Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (Naltrexone/Nicotine Patch)
Status:
Completed
Trial end date:
2003-05-01
Target enrollment:
Participant gender:
Summary
This study will develop a behavioral and drug relapse prevention program for individuals who
are dependent on both alcohol and tobacco. The study's goal is to show that individuals
receiving nicotine replacement therapy and naltrexone (Revia) with behavior therapy will have
higher rates of abstinence from both smoking and drinking than individuals who do not receive
the drug therapies. Individuals will be placed in a 12-week outpatient treatment program with
followup assessments 1, 3, and 6 months after treatment.
Phase:
Phase 4
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)